Protein protease inhibitors are the tools of nature in controlling proteolytic enzymes. They come in different shapes and sizes. The β -trefoil protease inhibitors that come from plants, fi rst discovered by Kunitz, were later complemented with representatives from higher fungi. They inhibit serine (families S1 and S8) and cysteine proteases (families C1 and C13) as well as other hydrolases. Their versatility is the result of the plasticity of the loops coming out of the stable β -trefoil scaffold. For this reason, they display several different mechanisms of inhibition involving different positions of the loops and their combinations. Natural diversity, as well as the initial successes in de novo protein engineering, makes the β -trefoil proteins a promising starting point for the generation of strong, specifi c, multitarget inhibitors capable of inhibiting multiple types of hydrolytic enzymes and simultaneously interacting with different protein, carbohydrate, or DNA molecules. This pool of knowledge opens up new possibilities for the exploration of their naturally occurring as well as modifi ed properties for applications in many fi elds of medicine, biotechnology, and agriculture.
Introduction
Protein inhibitors are the tools of nature that control proteolytic activity (Bode and Huber , 1992 ) . This proteolytic activity may originate from an endogenous source, from a hostile organism, or from the target organism attacked by a pathogen or a parasite. Correspondingly, the protein inhibitors may thus be deployed to regulate and prevent excessive proteolysis by endogenous proteases (reviewed by Turk et al. , 2002 ; Turk , 2006 ; Lopez -Otin and Matrisian, 2007 ) , defend against the attack of a pathogen or parasite (reviewed by Armstrong , 2001 ; Jongsma et al. , 2008 ) , or disable the proteolytic defense and repair mechanisms of the organism under attack (reviewed by . Because proteases have essential metabolic and regulatory functions in most biological processes, their protein inhibitors can be found in all forms of life (Rawlings , 2010 ) .
According to the MEROPS database, there are signifi cantly fewer inhibitors described than there are proteolytic enzymes (17 ° 451 vs. 192 ° 053 deposited sequences) (Rawlings et al. , 2011 ) . The reason for this most likely lies in their mechanism of action, where a single protein inhibitor can target an entire family of proteases. In general, emergency inhibitors, which need to prevent escaped proteolytic activity, have no need to be specifi c, whereas for regulatory inhibitors, a high specifi city against their target enzymes is required only in rare cases.
The pioneering work on protein protease inhibitors was carried out by Kunitz, who isolated trypsin inhibitors from bovine pancreases and soybeans, which were named the Kunitz type I and II inhibitors (Kunitz and Northrop , 1936 ; Kunitz , 1947a,b ) . Whereas type I inhibitors, such as the bovine pancreas trypsin inhibitor (BPTI), are relatively small, composed of 50-60 residues, type II inhibitors, such as the soybean trypsin inhibitor (STI), are larger, composed of 150-200 residues. The structure of the STI in a complex with trypsin was originally determined by Sweet et al. (1974) and later with an improved resolution by Song and Suh (1998) . The BPTI was extensively investigated by Huber and colleagues (Ruhlmann et al. , 1973 ; Huber et al. , 1974 Huber et al. , , 1975 Walter et al. , 1982 ; Bode et al. , 1984 ; Wlodawer et al. , 1984 ; Burgering et al. , 1997 ) .
The discoveries of Kunitz had a large impact on the research of protease inhibitors. For a long period, it was only the trypsin inhibitors that were dominating the fi eld (Laskowski and Qasim , 2000 ) . Surprisingly, many completely different folds were described, which all used the standard canonical inhibition mechanism (Bode and Huber , 1992 ; Krowarsch et al. , 2003 ) . The subsequent discoveries of protease inhibitors and the availability of the purifi ed and recombinant proteases led to the characterization of the inhibitors of proteases from various families and catalytic types, where some were also capable of inhibiting proteases from different families and clans. The latest review of inhibitors in the MEROPS database (Rawlings , 2010 ) indicates that of a total of 67 families that have been identifi ed, 24 inhibitor families are capable of inhibiting different protease families of one catalytic type and 11 families are capable of inhibiting proteases of different catalytic types.
Among the most versatile inhibitors with a broad specifi city, regarding the protease families that are inhibited, are the α -2-macroglobulins (family I39, inhibitors of endopeptidases of all catalytic types) and serpins (family I4, inhibitors of serine and cysteine endopeptidases); however, these are irreversible trapping inhibitors. They both use a similar trapping mechanism, where the bait region or the reactive loop is cleaved by the protease, leading to dramatic conformational changes in the inhibitor and, consequently, the disruption of the active site or enclosure of the protease (Barrett , 1981 ; Sottrup -Jensen et al., 1989 ; Huntington et al. , 2000 ) . Members of the IC clan of inhibitors are tightbinding, reversible inhibitors with a β -trefoil fold, and they display a similar versatility to the α -2-macroglobulins and serpins. The fi rst members of the IC clan were the Kunitz STI and its homologues, originating only from plants (family I3) that showed the inhibition of serine, aspartic, and cysteine proteases (families S1, S8, A1, and C1) (Laskowski and Kato , 1980 ; Mares et al. , 1989 ; Terada et al. , 1994 ; de Oliveira et al. , 2001 ) . Recent discoveries and the crystal structure determination of sequentially different β -trefoil inhibitors, isolated from mushrooms (MEROPS families I48, I66, and I85) (Sabotič et al., 2007 Avanzo et al. , 2009 ) , expanded the IC clan with new members, which signifi cantly broadened the level of diversity of the IC clan protease inhibitors with regard to the mechanism of inhibition and the position of the reactive-site loops (Renko et al. , 2010 ; .
This review describes the β -trefoil inhibitors, their structural similarity, their diversity, and their inhibitory potential for different types of hydrolytic enzymes. The gathered knowledge opens up new possibilities for an exploration of their naturally occurring as well as modifi ed properties for applications in many fi elds of medicine, biotechnology, and agriculture.
β -Trefoil fold
The β -trefoil fold is composed of 12 β -strands folded into three structurally similar units related by a pseudo-3-fold symmetry (Figure 1 ). The similarity between the three repeats can be detected by a structure-based alignment and residueproperty conservation, even though the sequence similarity is sometimes lower than 15 % (Murzin et al. , 1992 ; Xu and Xiao , 2005 ; Li et al. , 2008 ) . The alignment further suggests that proteins with the β -trefoil fold are all homologues and have a common ancestor that evolved by gene triplication (Ponting and Russell , 2000 ; Lee and Blaber , 2011 ) .
The fi rst reported crystal structure of a protein with the β -trefoil fold was the complex between STI and trypsin in 1974 Sweet et al. , 1974 ) . From that time, a number of crystal structures of the β -trefoil protease inhibitors were reported, mainly from plants, but lately also from the higher fungi (as discussed later).
The fold presented in the orientation in Figure 1D resembles a tree: the trunk formed by the six-stranded barrel, the roots composed of the loops connecting the strands from below, and the crown composed of three short pairs of β -strands and a coiled structure, each connecting two β -strands from the trunk. The total number of coiled regions within the loops connecting the β -strands in the structure is 11 (Renko et al. , 2010 ) .
The structure and sequence patterns of the β -trefoil proteins were analyzed by Murzin et al. (1992) , who showed that the six strands in the trunk region forming the β -barrel are tilted at an angle of 56 ° to the axis of the barrel and have a shear number of 12. The diameter of the β -barrel is 16 Å , which is 2 Å more than in the eight-stranded β -barrels, mainly because of the larger side chains forming the core (Lasters et al. , 1988 ; Murzin et al. , 1992 ) . The β -barrel core is formed from the side chains of three residues from each strand, all together 18, which are packed tightly in three layers.
The 12 β -strands forming the crown region are connected by loops. They constitute approximately half of the molecule. The loops between the β -strands are referred to by the β -strands to which they are attached (e.g., the loop that connects the β 1 and β 2 strands is called the β 1-β 2 loop).
An analysis of the selected, structurally aligned, eight protease inhibitors from Figure 2 shows a large variability in the lengths of these loops. The loop with the smallest variability is β 2-β 3, where the length is between 8 and 11 residues, whereas the largest variability is found in the β 11-β 12 loop, where the length is between six and 17 residues (Table 1 ) .
Biological functions of the β -trefoil proteins
Taking into account a small part of the structurally conserved basic scaffold consisting of the short β -barrel, the structurally very different loops, and the very low sequence homology, it is not surprising that the β -trefoil proteins display an extremely high plasticity with regard to their interaction partners, which include protein, carbohydrate, and DNA macromolecules.
The β -trefoil proteins can be divided into six groups based on their biological function. The fi rst group is classifi ed as hydrolase inhibitors; its representatives inhibit mostly proteases and are discussed in more detail below.
The second group is interleukins (ILs) belonging to the IL-1 family (Sims et al. , 2001 ) . They are small cell signaling molecules and play a central role in the regulation of the immune and infl ammatory responses (Dinarello , 2009 ) . The crystal structure and the site-directed mutagenesis showed that the IL-1B binds to the type 1 IL-1 receptor using two discrete binding sites involving several loops with a broad interaction surface (Evans et al. , 1995 ; Vigers et al. , 1997 ) .
The third group consists of fi broblast growth factors (FGFs) involved in the developmental signaling pathways important for cellular functions such as cell proliferation, survival, and migration (Turner and Grose , 2010 ) . The interaction interface is defi ned by the fi broblast growth factor receptor domain 2, the linker between domains 2 and 3, and the numerous loops on the FGF molecule (Plotnikov et al. , 1999 (Plotnikov et al. , , 2000 .
The fourth group includes lectins and carbohydrate-binding modules (CBMs). Although they both have the same function, which is glycan binding, they are divided into two subgroups, distinguished by their ability to modify glycans (carbohydrate hydrolases) or not (lectins). A number of folds can be used as CBMs; however, the β -trefoil fold is, among them, the second in terms of frequency (Boraston et al. , 2004 ) . Carbohydrates bind to a binding pocket that is usually defi ned by two or three loops (Transue et al. , 1997 ; Pohleven et al. , 2012 ) .
The fi fth group is represented by fascin, an actin crosslinking protein, which consists of four β -trefoil domains connected by one molecule of fascin (Sedeh et al. , 2010 ) . Fascin (D) The structure resembles a tree structure, with two loops in the root region, a stem built of a six-stranded β -barrel, and two layers of loops (6 + 3) in the crown region.
Figure 2
Structural alignment of selected proteinase inhibitors with a β -trefoil fold. 1AVU, STI; 1EYL, WCI; 1TIE, ETI; 2GZB, BbCI; 3E8L, API-A; 3H6Q, macrocypin; 3H6R, clitocypin; 3N0K, cospin. The β -strands are shown on a dark gray background, and the loops, involved in inhibition of S1, C1, and C13 family, are shown in red, blue, and green, respectively. Table 1 Loop-length variability in the selected protease inhibitors with a β -trefoil fold, aligned in Figure 2 .
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contains two major actin-binding sites, which coincide with the regions of high sequence conservation in the β -trefoil domains 1 and 3 (Chen et al. , 2010 ; Sedeh et al. , 2010 ) . The sixth group includes the multidomain DNA-binding protein LAG-1, which contains the β -trefoil domain at its N-terminus. LAG-1 can act as repressor or activator in the Notch signaling pathway, which is important for cell-cell communication in multicellular organisms. Portions of the N-terminal, β -trefoil domain, and the interdomain linker in LAG-1 produce an extensive electropositive and highly conserved surface through which the LAG-1 interacts with the DNA (Kovall and Hendrickson , 2004 ; Friedmann et al. , 2008 ) .
β -Trefoil protease inhibitors
Recently, reports on the β -trefoil inhibitors of proteases, mainly of plant origin, have been complemented by inhibitors of fungal origin (Brzin et al. , 2000 ; Sabotič et al., 2007 Sabotič et al., , 2009 Renko et al. , 2010 ) . Currently, there are more than 20 crystal structures of more than 10 different inhibitors with a β -trefoil fold deposited in the PDB (Berman et al. , 2000 ) . The list of available structures is summarized in Table 2 . They are included in the IC clan of the MEROPS classification according to their structural similarity. Based on their sequence similarity, they are further divided into four families: I3, with a representative of plant origin, and the families I48, I66, and I85, with members of fungal origin (Rawlings et al. , 2011 ) . Structurally, they all possess typical features of the β -trefoil fold that is the β -barrel trunk and the crown formed by six β -strands. In addition, there is also a long list of inhibitors whose crystal structure has not yet been determined; however, due to their sequence similarity, it is proposed that they share the β -trefoil fold (Oliva et al. , 2010 ) . With regard to their inhibitory profi le, β -trefoil inhibitors inhibit various catalytic classes of proteases.
Inhibition of the S1 family serine proteases
In accordance with their binding mechanism, there are three distinct classes of trypsin-like serine protease inhibitors: substrate-like binding canonical inhibitors blocking the active site (Bode and Huber , 1992 ) ; serpins, where the inhibitor remains covalently bound via the enzyme-acyl adduct (Huntington et al. , 2000 ) ; noncanonical inhibitors, found only in bloodsucking organisms and capable of inhibiting proteases in a blood clotting cascade (reviewed by Krowarsch et al. , 2003 ) .
The canonical inhibitors inhibit proteases by binding tightly to the active site of their target in a substrate-like manner. When bound, they undergo an extremely slow cleavage (Laskowskir , 1986 ; Bode and Huber , 1992 ; Radisky and Koshland , 2002 ) . Canonical inhibitors are the most abundant among the serine protease inhibitors (Laskowski and Kato , 1980 ; Laskowski , 1986 ) . They are further divided into 18 groups, based on their secondary structure (Laskowski and Qasim , 2000 ) . All 18 groups share a strikingly similar backbone conformation around the scissile peptide bond, although their folds are quite different (Bode and Huber , 1992 ; Radisky and Koshland , 2002 ) . Their specifi city is determined by the complementarity between the protease active-site cleft and the reactive loop of the inhibitor.
The best-known example of a serine protease in a complex with a canonical inhibitor is trypsin in a complex with the STI, where the Arg residue fi lls the hydrophobic and negatively charged S1-binding site (Figure 3 A) Song and Suh , 1998 ) . The S1-binding site is the major determinant of specifi city. It is differently shaped in different serine proteases; however, multiple residues can fi ll it, albeit with a reduced affi nity (Kojima et al. , 1991 ) . For example, the trypsin S1-binding site is negatively charged and preferentially accepts Arg and Lys; thrombin prefers Arg , whereas the chymotrypsin S1-binding site is not charged and accepts large hydrophobic residues such as Tyr, Phe, and Leu (Sigler et al. , 1968 ) .
The canonical conformation of the reactive loop is stabilized in a number of ways: by hydrogen bonds, disulfi de bonds, or hydrophobic interactions, which can involve residues either from the reactive loop or scaffold residues (Song and Suh , 1998 ; Ravichandran et al. , 1999 ) . Radisky et al. (2003 Radisky et al. ( , 2004 Radisky et al. ( , 2005 showed that the residues Arg65 and Arg67, located in the core of the chymotrypsin inhibitor 2 of the potato inhibitor 1 family, act as a spacer and that mutations of these arginines or their interacting partners disrupt the canonical conformation, resulting in the increased hydrolysis of the scissile bond. Dasgupta et al. (2006) analyzed the structures of the β -trefoil inhibitors available at that time and discovered that the conserved Asn14 in the STI serves as a scaffold residue ( Figure 3A -C) , which maintains the reactive loop in a canonical conformation by numerous hydrogen bonds, formed between the side chain of the Asn and the main chain atoms of the reactive loop, thereby maintaining the reactive loop in the canonical conformation (Ravichandran et al. , 2001 ) . Mutations of this residue in the winged bean chymotrypsin inhibitor (WCI) signifi cantly reduced its inhibitory properties (Dasgupta et al. , 2006 ) . Further mutation studies with this inhibitor identifi ed additional residues (Arg74, Trp88, and Tyr113), which are needed for the stabilization of the canonical loop conformation and therefore the inhibition of the serine proteases (Khamrui et al. , 2010 ) .
Apart from the STI and the WCI, the conserved Asn is also present in the inhibitor from Erythina caffra seeds, the inhibitor from Copaifera langsdorffi i (CTI), the kallikrein inhibitor from Bauhinia bauhinioides (BbKI), and the cruzipain inhibitor from B. bauhinioides (BbCI), but not in others.
The β -trefoil inhibitors that do not have the conserved Asn residue stabilize the canonical conformation of the reactive loop in different ways. The second reactive loop in the twoheaded arrowhead protease inhibitor API-A, located at the β 9-β 10 loop, uses two disulfi de bonds to support the reactive loop conformation (Azarkan et al. , 2010 ) . The bonds are formed between the cysteine residues located at the P2-P5 and P7-P3 ′ positions ( Figure 3D ). In another case, cospin (PIC), the Asn residue is replaced by two long residues, which β-Trefoil inhibitors 1047 Table 2 Overview of β -trefoil protease inhibitors with an emphasis on the reactive loop involved in inhibition of S1 family proteases. Asn14 Kunitz , 1947b ; Sweet et al. , 1974 ; De Meester et al. , 1998 ; Song and Suh , 1998 WCI 1EYL, 4WBC, 2QYI S1 β 4- Kortt , 1980 ; Ravichandran et al. , 1999 Ravichandran et al. , , 2001 Inhibitor from E. caffra support the canonical conformation of the reactive loop like arginines in the case of the chymotrypsin inhibitor 2 of the potato inhibitor 1 family (Radisky et al. , 2003 (Radisky et al. , , 2004 (Radisky et al. , , 2005 . Furthermore, the Lys at the P5 ′ position is oriented away from the protein core and makes three hydrogen bonds with the main-and side-chain atoms of the Ser residue at P1 ′ and the main-chain atoms of the Leu at P3 ′ , respectively. Additionally, the Glu at the P3 position points toward the protein core and forms hydrogen bonds with the protein core and further stabilizes the loop conformation ( Figure 3F ). The inhibitor from Delonix regia (Krauchenco et al. , 2003 ) and the second inhibitory loop ( β 4-β 5) from the papaya protease inhibitor (PPI) (Azarkan et al. , 2010 ) , however, do not use their own residues to maintain the canonical conformation. In these cases, a water molecule located close to the scissile bond supports the reactive loop conformation by forming a hydrogen bond network between the main-chain atoms of the reactive loop and the core of the inhibitor. Also in the case of the D. regia inhibitor ( Figure 3E ), a water molecule bridges the interaction between the P2 and the P5 residues of the loop. Possibly due to a number of different ways of maintaining the inhibitory conformation of the reactive loop, a comparison of the sequences of the reactive loops reveals no consensus, except for the conserved Arg or Lys at the P1 position ( Table 2) .
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Inhibition of the S8 family serine proteases
The catalytic mechanism and the position of the catalytic triad of subtilisin and the other proteases from the S8 family are identical to the trypsin-like proteases (S1). They are, however, structurally and evolutionarily distinct (Smith et al. , 1966 ; Wright et al. , 1969 ; Betzel et al. , 1992 ) . The most important difference in the active site between the two families is in the binding site specifi city. Whereas the trypsin specifi city is mainly determined by the single large S1-binding site selective for Arg or Lys, the specifi city of the subtilisin is rather broad and is determined by the two S1-and S4-binding sites (Wright et al. , 1969 ) . Due to the wide industrial use of subtilisin, there were numerous attempts to modify its specifi city (Rheinnecker et al. , 1993 (Rheinnecker et al. , , 1994 Takagi et al. , 1997 ) .
The barley α -amylase/subtilisin inhibitor (BASI) is the only β -trefoil inhibitor of subtilisin-like proteases for which the crystal structure is determined in the complex with savinase (subtilisin-like protease from Bacillus lentus ). The BASI binds to the savinase in a substrate-like manner and forms a β -strand in the P5-P2 region alongside the active site (Figure 4 ) . Numerous interactions between this region and the savinase active site are present, including seven hydrogen bonds between the main-chain atoms of the BASI and the savinase residues (Micheelsen et al. , 2008 ) . The P1 and P1 ′ residues do not interact with savinase because the loop is pulled out of the cleft by the disulfi de bond of the P1 residue (Cys90) formed with the Cys43 of the inhibitor. The potential scissile bond is therefore pulled away from the active-site serine residue. Therefore, the BASI is not degraded, in contrast to the other serine protease inhibitors.
Inhibition of the C1 family cysteine proteases
The C1 family comprises the papain-like cysteine proteases. In contrast to the S1 family of serine proteases, they display a low specifi city due to the less strictly defi ned substrate binding sites (Turk et al. , 1998 ) . Additionally, the C1 proteases do not possess an enclosed P1 substrate residue-binding pocket. There is only a binding surface at which the P1 residue side chain points away from the protein core. Likely, substrate-like binding of an inhibitor in the position that locks the reactive the structure of clitocypin in the complex with cathepsin V was determined (Renko et al. , 2010 ) . In the cathepsin V and clitocypin complex, the fi rst interacting loop β 1-β 2 binds into the nonprimed substrate-binding sites and the second loop β 3-β 4 binds into the primed substrate-binding sites. These two loops occlude the catalytic cysteine in the middle, thereby preventing the approach of substrate molecules ( Figure 5 ). Both binding loops appear rather rigid, and each contains two proline residues. The fi rst one is stabilized by the Arg14 side chain, which spans the broad loop, and forms a hydrogen bond with the carbonyl group of Gly 22, whereas the second loop is rigidifi ed by a short helix where N-terminus two proline residues reside. The chain from the fi rst binding loop comes down the S3-binding area of the cathepsin V, occupies the S2-binding site with Val23 and continues through the S1-binding site, upward and away from the cathepsin V surface. The second binding loop of clitocypin approaches the S1 ′ and S2 ′ binding sites of cathepsin V from the top. Both loops are fastened to the cathepsin V surface by a number of hydrogen bonds. Several contacts are also mediated through solvent molecules. Of note is the peptide bond fl ip between the conserved residues Gly24 and Gly25 of the clitocypin. They are positioned within the fi rst binding loop region in the complex. This fl ipped peptide bond makes a contact with the reactive-site cysteine (Renko et al. , 2010 ) .
The acquired knowledge about the modes of binding of the β -trefoil inhibitors to cathepsin V (C1) and trypsin (S1) questions the suggestion that in BbCI the same loop may be loop could not be achieved due to the relatively short activesite cleft and the absence of an inward-oriented S1 substratebinding site. As a consequence, the proteins binding to C1 proteases in a substrate-like manner can be only degraded.
Protein inhibitors of papain-like cysteine proteases therefore use a different mechanism than inhibitors of the S1 serine proteases. Although the inhibitory mechanism of the serine proteases involves substrate-like binding with only one reactive loop, the cysteine protease inhibitors usually use two or three loops, which bind to the prime and nonprime binding sites. They do not directly interact with the active-site residues. Instead, they occlude the active-site cysteine residue and prevent the approach of substrates (Stubbs et al. , 1990 ; Turk et al. , 1997 Turk et al. , , 2012 Gunčar et al., 1999 ; Wang et al. , 2007 ) .
There are several reports that β -trefoil inhibitors also inhibit papain-like cysteine proteases. The cysteine protease inhibitor PCPI 8.3, isolated from potato tubers, was classifi ed as β -trefoil on the basis of the sequence homology (Krizaj et al. , 1993 ) . BbCI was fi rst classifi ed as a β -trefoil inhibitor by its sequence homology (de Oliveira et al. , 2001 ) and later confi rmed by its crystal structure (Hansen et al. , 2007 ) . It was suggested that the same reactive loop that is responsible for the inhibition of the serine proteases is also responsible for the inhibition of the cysteine proteases. The key evidence for the hypothesis of a common interaction site was the cleavage of the serine protease interacting loop after the incubation of the BbCI with cruzipain (Hansen et al. , 2007 ) . Based on modeling and docking experiments, Franco et al. (2002) suggested that the same loop of the inhibitor from Prosopis julifl ora is involved in the cysteine and serine protease inhibition.
Clitocypins and macrocypins were known to inhibit cysteine proteases (Brzin et al. , 2000 ; Sabotič et al., 2007 Sabotič et al., , 2009 ) but were not classifi ed as inhibitors with the β -trefoil fold until Figure 4 The structure of BASI in complex with subtilisin-like protease savinase. P5-P2 residues in β -strand conformation form numerous hydrogen bonds. The scissile bond P1-P1 ′ is pulled away from the active-site serine residue (yellow surface) by intramolecular disulfi de bond (yellow sticks). Binding loops of clitocypin in its complex with cathepsin V. Clitocypin loops are shown as sticks. Only main-chain atoms, without the carbonyl oxygen atom and side chains, are shown. Nitrogen atoms are shown in blue, oxygen in black, and carbon in red, with the exception of the Gly24-Gly25 part, shown in orange. The surface of cathepsin V is shown in gray, apart from the catalytic cysteine, shown in yellow, and the S3, S2, S1, S1 ′ , and S2 ′ binding site, shown in green and cyan. The chain of the fi rst binding loop comes down the S3-binding area of cathepsin V, occupies the S2-binding site, and continues upward through the S1-binding site. The second binding loop of clitocypin approaches the S1 ′ and S2 ′ binding sites of cathepsin V from the top. responsible for inhibiting both groups of enzymes. The superimposition of the structure of BbCI on the clitocypin in a complex with cathepsin V showed that two broad loops in the BbCI structure are equivalent to the clitocypin-binding loops (Renko et al. , 2010 ) . Taking into account the differences between the papain-like and the trypsin-like substrate-binding architecture, these together suggest that these two loops are probably responsible for the cathepsin L and cruzipain inhibition and not the loop containing the trypsin cleavage site (Hansen et al. , 2007 ) .
When comparing the inhibition of papain-like cysteine proteases by different inhibitors, it appears that the occlusion of the reactive-site cysteine is the common denominator of their binding. In addition to the mycocypins, the mode of inhibitor binding to the C1 protease has been described for the cystatin (I25) (Stubbs et al. , 1990 ) and thyropin (I31) families (Gunčar et al., 1999 ) as well as for chagasin (I42) (Wang et al. , 2007 ; Redzynia et al. , 2008 ) . The inhibitors from these families have completely different folds but still use different loops to occlude the active-site residues. In contrast to two loops in clitocypins, proteins such as cystatins, thyropins, and chagasin provide three loops, which fi ll the active-site cleft (Stubbs et al. , 1990 ; Gunč ar et al., 1999 ; Wang et al. , 2007 ; Redzynia et al. , 2008 ) .
Inhibition of the C13 family cysteine proteases
Asparaginyl endopeptidase (AEP), also known as legumain, is a cysteine protease belonging to the C13 family. It specifically cleaves the peptide bonds with Asn or Asp at the P1 position (Kembhavi et al. , 1993 ; Chen et al. , 1997 ) . The sequence similarity and the presence of the conserved activesite motif suggested that the AEP is structurally related to caspases and gingipains (Chen et al. , 1998 ; Shutov et al. , 2012 ) . Although the crystal structure of AEP is not yet known, the crystal structures of gingipain R and caspase 1 (Wilson et al. , 1994 ; Eichinger et al. , 1999 ) and substrate-specifi city studies (Dando et al. , 1999 ; Mathieu et al. , 2002 ) suggest that the S1-binding site must be a well-defi ned pocket specifi c for Asp and Asn residues.
Until now, clitocypin and macrocypins are the only known β -trefoil inhibitors capable of AEP inhibition (Sabotič et al., 2007 ). The fact that AEP is structurally unrelated to the papain-like proteases and that the naturally occurring mutant in macrocypins, where the P1 Asn residue is replaced by Lys, switches the legumain inhibitor to a trypsin inhibitor suggest that the inhibitory mechanism of the cysteine protease AEP (C13) is likely to be similar to the substrate-like binding inhibition of the serine protease trypsin (S1) rather than the inhibition of the papain-like cysteine proteases of (C1) by occlusion of the reactive-site cysteine with the two binding loops.
Inhibition of amylases
Amylases are hydrolytic enzymes that catalyze the hydrolysis of the glycosidic bonds in α -1,4-linked sugar polymers, such as starch and glycogen, resulting in their degradation into oligosaccharides. Although amylases are not proteases, they are yet another type of hydrolases that is inhibited by the β -trefoil proteins, again showing that the versatile and potent loops are capable of an interaction with diverse protein partners.
The interaction of the inhibitor with the barley amylase is different to the previously described interactions of inhibitors with cognate proteases. Here, numerous loops, β 2-β 2, β 3-β 4, β 6-β 7, β 9-β 10, and β 11-β 12, are involved in the interaction of the BASI with barley amylase. Although there is no direct interaction of the BASI with the amylase catalytic residues, it still prevents the access of the substrates to the active-site cleft (Vallee et al. , 1998 ) , which is similar to the inhibition of C1 proteases.
Engineering β -trefoil inhibitors
Potent interacting loops that differ in shape and composition incorporated into the β -trefoil fold are able to inhibit several classes of proteases, including cysteine cathepsins, AEP, cruzipain, trypsin, chymotrypsin, elastase, subtilisin, as well as glycosidases, including amylases. The initial research of Kunitz, which indicated that β -trefoil inhibitors are only serine protease inhibitors, infl uenced the fi eld, and for a long period, these proteins were typically tested for the inhibition of trypsin-like serine proteases and seldom with proteases of different families or even different catalytic types. Recent research demonstrated that β -trefoil inhibitors are extremely versatile with regard to their interaction partners, suggesting that their potential for possible interactions with various proteases as well as other enzymes should be routinely examined. However, the broad inhibitory spectra should not be confused with broad specifi city as, for example, is seen with the α -2-macroglobulins and serpins. Despite the high versatility and the broad inhibitory spectrum, individual β -trefoil inhibitors can distinguish between similar proteases of the same family (Sabotič et al., 2007 .
In addition to a protein-protein interaction, interactions with carbohydrates and DNA have been described. It was also shown that some β -trefoil fold proteins (e.g., macrocypin, clitocypins, several lectins) are extremely resistant to extreme values of pH, proteolytic degradation, and exposure to high temperature (Kidrič et al., 2002 ; Gale š a et al., 2004 ; Azarkan et al. , 2006 ; Sun et al. , 2008 ) , which makes them resistant to unfolding and digestion. It has already been shown that several β -trefoil inhibitors exhibit entomotoxic or insecticidal properties against several important crop pests and model insects where they can inhibit various digestive proteases (Lawrence and Koundal , 2002 ; Habib and Fazili , 2007 ; . The versatility of their biological functions makes β -trefoil proteins a promising starting point for the generation of strong, specifi c, multitarget inhibitors, capable of inhibiting not only proteases but also multiple types of enzymes as well as of a simultaneous interaction with different protein, carbohydrate, or DNA molecules.
The fi rst engineering studies by Khamrui et al. (2010) resulted in the chimeric proteins ECI-WCI, ETI-WCI, and STI-WCI, where the reactive loops from the Erythrina variegate chymotrypsin inhibitor (ECI), the Erthrina caffra trypsin inhibitor (ETI), and soybean trypsin inhibitor (STI) were placed on the scaffold of the homologous WCI. Whereas the ETI-WCI behaved as a substrate, the STI-WCI and ECI-WCI retained the inhibitory properties similar to that of the native WCI (Khamrui et al. , 2010 ) . Another attempt to engineer β -trefoil inhibitors was performed in the case of macrocypins, where the inhibition properties against trypsin or legumain between macrocypin 1 and macrocypin 4 were reversed by simply exchanging a few residues in the reactive loops (Renko et al. , 2010 ) . Completely different approaches were used by Brych et al. (2001) and Lee and Blaber (2011) , where they successfully designed and produced a de novo protein with a symmetrical primary structure.
Although the production of chimeric mutants with inhibitory properties from two different proteins is not straightforward and different scaffold residues have to be taken into the account (Khamrui et al. , 2010 ) , it can be expected that in the near future not only de novo proteins with a defi ned secondary structure (Lee and Blaber , 2011 ) but also de novo hydrolase inhibitors with specifi cally engineered multiple reactive loops will be produced.
